Articaine is a form of an amide local anesthetic that is most commonly used in dentistry. This drug is originally known as carticaine. It has different molecular structure with a thiophene ring instead of the usual benzene ring present in the other amide anesthetic drugs. The half-life of Articaine is 1.8 hours. Like other amide anesthetics it blocks nerve conduction when it is inflated around a nerve. The action of articaine can be prolonged by combining it with a vasoconstrictor such as adrenaline.
The global market of articaine hydrochlorides is expected to reach USD 1363.0 million by 2021, at a CAGR of 7.0% during the forecast period. Based on application, the nerve block segment is the fastest growing one and it is expected to reach USD 624.8 million by 2021. Based on end users, the dental clinics segment commands the largest market share and it is expected to grow at 7.1% CAGR during the forecast period.
Articaine is the second most used local anesthetic in the U.S., with a share of around 40%. Articaine hydrochloride is most popular local anesthetic for dentistry in a number of European countries. Germany is the biggest buyer of articaine hydrochloride, with 97% dentists using it as an anesthetic. In Australia, around 70% of the dentists use articaine as local anesthetic. Within Asia, China is one of the biggest producers of Articaine hydrochloride and its products are mostly exported to Middle East and Europe.
The leading market players in the global articaine hydrochloride market include; Anhui BBCA Pharmaceutical Co., Ltd (China), Cayman Chemical (USA), Jinan Chinghai Shuangda Chemical Co., Ltd. (China), Pierrel S.p.a, Sanofi (France), Sigma Aldrich (Germany), Siegfried AG (Switzerland), Septodent (USA), 3M, Inibsa Laboratories and many others.
Ø To provide insights about factors influencing and affecting the market growth.
Ø To provide historical and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
Ø To provide historical and forecast revenue of the market segments based on application, and end users for global articaine hydrochloride market.
Ø To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
Ø Articaine hydrochloride manufacturers
Ø Articaine API manufacturers
Ø Articaine hydrochloride suppliers
Ø Research Laboratories
Ø Hospitals & Clinics
Ø Service Suppliers
Ø Potential Investors
Ø Key executive (CEO and COO) and strategy growth manager
• The global market for articaine hydrochloride is expected to grow at 7.0% CAGR during the forecast period
• Asia-Pacific market is expected to achieve the fastest growth and Europe is projected to be the largest market during the forecast period
• Infiltration application segment is expected to witness highest growth of 6.9% CAGR between 2016 and 2021.
• Dental clinics end-user held the largest share of 74.6% within the global articaine hydrochloride market, in 2015
Asia-Pacific articaine hydrochloride market is poised to reach USD 529 million by 2021, growing at around 7.3% CAGR during the forecast period. The North America market was valued at USD 366.7 million in 2015, and expected to reach USD 605.4 million by 2021.
The report covers country level analysis:
• North America
o Rest of Western Europe
o Eastern Europe
o Republic of Korea
o Rest of Asia-Pacific
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)